A Pathology‐Instructed Theranostic Platform with Mechanoadaptive and ROS‐Powered Nanobreathing Functions for Precision Myocardial Repair
Advanced Science · 2026
DOI: 10.1002/advs.76312 ↗At a glance
Journal article in Advanced Science, 2026. Written by Zheng Luo and 7 co-authors. Institution: Center of Burn & Plastic and Wound Healing Surgery, The First Affiliated Hospital of University of South China, Hengyang Medical School, University o…. Major MEDLINE topics: Myocardial Infarction, Reactive Oxygen Species, Theranostic Nanomedicine, Hydrogels. 50 references. The full text is freely available (open access, CC BY 4.0). Funded by: Natural Science Foundation of China, Fujian Provincial Natural Science Foundation of China, Health Research Project of Hunan Provincial Health Commission.
Abstract (original language)
Current myocardial infarction (MI) biomaterials often fail to dynamically adapt to the evolving pathological microenvironment (e.g., ROS bursts, hypoxia), lacking both mechanical compatibility and in situ feedback. To overcome these limitations, we developed an albumin hydrogel platform (BST) with a closed‐loop pathological response system. BST is a pH‐responsive hydrogel, functionalized with MRI/CT probes and loaded with mitochondria‐targeted CAT‐SOD enzyme nanogels (CSDT). It forms a self‐repairing scaffold with high shear viscosity (∼300 Pa·s), elasticity, and cardiac‐like mechanics (∼7.5 kPa), stabilizing the infarct wall. Hypoxia‐induced acidosis triggers the release of CSDT nanogels and albumin, enabling mitochondrial ROS scavenging and O 2 generation, while albumin restores tissue osmotic balance. These actions collectively alleviate oxidative stress, modulate immune responses, and promote cardiomyocyte survival by enhancing autophagy and anti‐apoptotic pathways. This inside‐out feedback mechanism reverses oxidative stress and hypoxia, shifts macrophages to a reparative M2 phenotype, and increases angiogenesis by ∼2.5‐fold. In an MI mouse model, BST, with programmable biodegradation (∼3 weeks), restored left ventricular ejection fraction to ∼70% of sham group and improved 28‐day survival by ∼2.5‐fold. Furthermore, BST enables real‐time MRI/CT tracking of material retention and tissue repair dynamically, permitting spatiotemporal control of the infarct microenvironment and advancing precision MI therapy toward clinical translation.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Center of Burn & Plastic and Wound Healing Surgery, The First Affiliated Hospital of University of South China, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
- State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Faculty of Medicine and…
- Institute of Materials Research and Engineering (IMRE), Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore.
- School of Medicine, Xiamen University, Xiamen, China.
ORCID profiles: Xian Jun Loh
Funding
- Natural Science Foundation of China
- Fujian Provincial Natural Science Foundation of China
- Health Research Project of Hunan Provincial Health Commission
- Scientific Research Fund of Hunan Provincial Education Department
- National Natural Science Foundation of China
Cite
APA
Luo, Z., Yang, C., Mao, L., Ma, P., Jia, C., Tang, K. Y., Loh, X. J., & Wu, Y. L. (2026). A Pathology‐Instructed Theranostic Platform with Mechanoadaptive and ROS‐Powered Nanobreathing Functions for Precision Myocardial Repair. Advanced Science. https://doi.org/10.1002/advs.76312
Vancouver
Luo Z, Yang C, Mao L, Ma P, Jia C, Tang KY, et al. A Pathology‐Instructed Theranostic Platform with Mechanoadaptive and ROS‐Powered Nanobreathing Functions for Precision Myocardial Repair. Advanced Science. 2026. doi:10.1002/advs.76312
BibTeX
@article{Luo2026,
author = {Luo, Zheng and Yang, Cui and Mao, Liuzhou and Ma, Panqin and Jia, Chiyu and Tang, Karen Yuanting and Loh, Xian Jun and Wu, Yun-Long},
title = {A Pathology‐Instructed Theranostic Platform with Mechanoadaptive and ROS‐Powered Nanobreathing Functions for Precision Myocardial Repair},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.76312}
}
EUVIMED